We would like to invite you to the **19th Webinar** organized by the Early Career Investigators network under the TRANSLACORE project, scheduled for **15 April at 14:00 PM CET online**.


The meeting will include the following:

**Introduction:**

Current research underscores the pivotal role of RNA-mediated regulation in cell death and oncogenesis. This webinar integrates two complementary perspectives: the influence of m6A RNA modifications on the apoptotic translatome under stress, and the epigenetic impact of miR-770-5p on histone modifiers and signaling pathways in breast cancer. By bridging post-transcriptional and epigenetic mechanisms, these findings provide critical insights into cancer progression and identify potential therapeutic targets.

- Decoding the Apoptotic Translatome: The Impact of m6A Modification Under Differential Cell Death Triggers – by **Azime Akçaöz**, Research assistant, Department of Molecular Biology and Genetics, Izmir Institute of Technology, Türkiye 
- Epigenetic Functions of miR-770-5p in Breast Cancer: Targeting Histone Modifiers and Growth Factor Signaling – by **Senem Noyan**, Postdoctoral Researcher, Ankara University Biotechnology Institute, Türkiye

Organising committee:

- Sophie Gomez
- Adolfo Rivero-Müller
- Paula Alepuz
- Nikolaos Balatsos
- Rafaela Lacerda Santos
- Paulina Podszywalow
- Gamze Guney Eskiler
- Cecilia Picazo
- Caroline Moyret Lalle




We would like to invite you to the 19th Webinar organized by the Early Career Investigators network under the TRANSLACORE project, scheduled for 15 April at 14:00 PM CET online.

Azime Akçaöz

Senem Noyan

19th Webinar for Early Career Investigators

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

19th Webinar for Early Career Investigators